Medline Industries will pay $167.5m for the Namic brand of manifolds, contrast management systems, closed fluid systems, guidewires, disposable transducers and interventional accessories. It also includes a manufacturing facility and the manufacturing, sales and marketing staff that support Namic.

The global infusion drug delivery market continues to be driven by the rising prevalence of chronic disease and associated obesity, coupled with a growing aging population. Technological advancements such as less invasive pumps, needlestick prevention features and miniaturization have also supported the growing demand, but obstacles such as safety and security issues remain. According to a new report by Meddevicetracker, the global market for infusion pumps and disposables will reach $9.9bn by 2022, a CAGR of 6.4% from 2017. This article takes an in-depth look at the overall infusion pumps market, and dives deeper into the three fastest-growing segments – insulin, enteral and disposable pumps – highlighting the key players and competitive landscape.

A California court is allowing a class-action case filed by health-care professionals against the company to go forward, while competitor Medline files suit alleging false advertising. Kimberly-Clark allegedly promoted its MicroCool and Ultra surgical gowns as meeting high safety standards, even though they failed lab testing.

Founded with the intent to invest in companies that bring value to health care, HealthQuest Capital continues to find strong interest from limited partners and unique companies to back.